Lum Kirsten J, Sundaram Rajeshwari, Barr Dana B, Louis Thomas A, Buck Louis Germaine M
From the aDivision of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Rockville, MD; bDepartment of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD; and cDepartment of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, GA.
Epidemiology. 2017 Jan;28(1):90-98. doi: 10.1097/EDE.0000000000000552.
Perfluoroalkyl substances have been associated with changes in menstrual cycle characteristics and fecundity, when modeled separately. However, these outcomes are biologically related, and we evaluate their joint association with exposure to perfluoroalkyl substances.
We recruited 501 couples from Michigan and Texas in 2005-2009 upon their discontinuing contraception and followed them until pregnancy or 12 months of trying. Female partners provided a serum sample on enrollment and completed daily journals on menstruation, intercourse, and pregnancy test results. We measured seven perfluoroalkyl substances in serum using liquid chromatography-tandem mass spectrometry. We assessed the association between perfluoroalkyl substances and menstrual cycle length using accelerated failure time models and between perfluoroalkyl substances and fecundity using a Bayesian joint modeling approach to incorporate cycle length.
Menstrual cycles were 3% longer comparing women in the second versus first tertile of perfluorodecanoate (PFDeA; acceleration factor [AF] = 1.03, 95% credible interval [CrI] = [1.00, 1.05]), but 2% shorter for women in the highest versus lowest tertile of perfluorooctanoic acid (PFOA; AF = 0.98, 95% CrI = [0.96, 1.00]). When accounting for cycle length, relevant covariates, and remaining perfluoroalkyl substances, the probability of pregnancy was lower for women in second versus first tertile of perfluorononanoate (PFNA; odds ratio [OR] = 0.6, 95% CrI = [0.4, 1.0]) although not when comparing the highest versus lowest (OR = 0.7, 95% CrI = [0.3, 1.1]) tertile.
In this prospective cohort study, we observed associations between two perfluoroalkyl substances and menstrual cycle length changes, and between select perfluoroalkyl substances and diminished fecundity at some (but not all) concentrations. See video abstract at, http://links.lww.com/EDE/B136.
全氟烷基物质在单独建模时,已被证明与月经周期特征和生育力的变化有关。然而,这些结果在生物学上是相关的,因此我们评估它们与全氟烷基物质暴露的联合关联。
2005年至2009年期间,我们从密歇根州和得克萨斯州招募了501对夫妇,他们停止避孕后,对其进行跟踪,直至怀孕或尝试12个月。女性伴侣在登记时提供血清样本,并记录每日的月经、性交和妊娠试验结果。我们使用液相色谱-串联质谱法测量血清中的七种全氟烷基物质。我们使用加速失效时间模型评估全氟烷基物质与月经周期长度之间的关联,并使用贝叶斯联合建模方法结合周期长度来评估全氟烷基物质与生育力之间的关联。
与全氟癸酸(PFDeA)处于第二个三分位数的女性相比,处于第一个三分位数的女性月经周期长3%(加速因子[AF]=1.03,95%可信区间[CrI]=[1.00,1.05]),但与全氟辛酸(PFOA)处于最高三分位数的女性相比,处于最低三分位数的女性月经周期短2%(AF=0.98,95%CrI=[0.96,1.00])。在考虑周期长度、相关协变量和其余全氟烷基物质后,与全氟壬酸(PFNA)处于第二个三分位数的女性相比,处于第一个三分位数的女性怀孕概率较低(优势比[OR]=0.6,95%CrI=[0.4,1.0]),但在比较最高与最低三分位数时则不然(OR=0.7,95%CrI=[0.3,1.1])。
在这项前瞻性队列研究中,我们观察到两种全氟烷基物质与月经周期长度变化之间存在关联,以及某些(但不是所有)浓度的特定全氟烷基物质与生育力下降之间存在关联。见视频摘要:http://links.lww.com/EDE/B136。